GENETRON HOLDINGS LTD-ADR (GTH) Stock News
NASDAQ:GTH - Nasdaq - US37186H2094 - ADR - Currency: USD
GTH Latest News, Press Relases and Analysis
Genetron Health Announces Completion of Going Private Transaction
Genetron Health Announces Completion of Going Private Transaction
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...
Genetron Health shareholders approve merger to go private (NASDAQ:GTH)
Genetron Holdings' shareholders have approved the proposed merger agreement with New Genetron Holding Limited and Genetron New Co Limited.
Genetron Health Announces Shareholders’ Approval of Merger Agreement
BEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health Announces Shareholders’ Approval of Merger Agreement
Genetron Health to Hold Extraordinary General Meeting of Shareholders
BEIJING, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health to Hold Extraordinary General Meeting of Shareholders
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning!
Genetron Holdings enters into merger agreement to go private (NASDAQ:GTH)
Genetron Holdings announces definitive merger agreement with New Genetron, indicating an equity value of ~$126M and an expected first-quarter 2024 closing.
Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction
BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction
Genetron Health receives Nasdaq notice for non-compliance (NASDAQ:GTH)
Genetron (GTH) received Nasdaq notice dated May 17, 2023, indicating that for the last 30 consecutive business days, the closing bid price for the company’s ADSs was below the minimum...
Genetron Health Announces Receipt of Notification from Nasdaq
BEIJING, May 23, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology...
Genetron Health Regains Compliance With Nasdaq Minimum Bid Price Requirement
BEIJING, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology...
Genetron Health Announces Receipt of Notification from Nasdaq
BEIJING, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology...
Genetron Health Reports Unaudited Second Quarter 2022 Financial Results
BEIJING, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology...
Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
BEIJING, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
BEIJING, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day
BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...
Genetron Health Receives CAP Accreditation for its Maryland Laboratory
BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health Reports Unaudited First Quarter 2022 Financial Results
BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...
Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes
BEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...
Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022
BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...
HFCAA News: 128 Chinese Stocks the SEC Could Delist
The SEC has released a massive list of Chinese stocks that could face delisting on Holding Foreign Companies Accountable Act news.